{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:20:55Z","timestamp":1790878855199,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1056-5","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T08:22:50Z","timestamp":1538727770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)"],"prefix":"10.1186","volume":"19","author":[{"given":"Suguru","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Karaboyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Komaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"De Sequera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Christensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Pisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"issue":"3S1","key":"1056_CR1","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2018.01.002","volume":"71","author":"R Saran","year":"2018","unstructured":"Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, Balkrishnan R, Dietrich X, Eckard A, Eggers PW, et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3S1):A7.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"1056_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945\u201353.","journal-title":"Kidney Int"},{"issue":"5","key":"1056_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s40620-017-0404-z","volume":"30","author":"J Bover","year":"2017","unstructured":"Bover J, Bailone L, Lopez-Baez V, Benito S, Ciceri P, Galassi A, Cozzolino M. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations. J Nephrol. 2017;30(5):677\u201387.","journal-title":"J Nephrol"},{"issue":"5","key":"1056_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40620-017-0398-6","volume":"30","author":"PAU Torres","year":"2017","unstructured":"Torres PAU, Cohen-Solal M. Evaluation of fracture risk in chronic kidney disease. J Nephrol. 2017;30(5):653\u201361.","journal-title":"J Nephrol"},{"issue":"1","key":"1056_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10(1):98\u2013109.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1056_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2008;52(3):519\u201330.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1056_CR7","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","volume":"26","author":"J. Floege","year":"2010","unstructured":"Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G et al: Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011, 26(6):1948\u20131955.","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"1056_CR8","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fernandez-Martin","year":"2015","unstructured":"Fernandez-Martin JL, Martinez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, Locatelli F, Gorriz JL, Rutkowski B, Ferreira A, et al. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant. 2015;30(9):1542\u201351.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1056_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/1744-9987.12030","volume":"17","author":"M Taniguchi","year":"2013","unstructured":"Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y, et al. Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial. 2013;17(2):221\u20138.","journal-title":"Ther Apher Dial"},{"issue":"7","key":"1056_CR10","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, Mason N, Prutz KG, Young EW, Pisoni RL. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis outcomes and practice patterns study. Kidney Int. 2006;70(7):1358\u201366.","journal-title":"Kidney Int"},{"issue":"5","key":"1056_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40620-017-0406-x","volume":"30","author":"S Yamamoto","year":"2017","unstructured":"Yamamoto S, Fukagawa M. Uremic toxicity and bone in CKD. J Nephrol. 2017;30(5):623\u20137.","journal-title":"J Nephrol"},{"issue":"09","key":"1056_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5414\/CN108827","volume":"86","author":"Antonio Bellasi","year":"2016","unstructured":"Bellasi A, Cozzolino M, Russo D, Molony D, Di Iorio B: Cinacalcet but not vitamin D use modulates the survival benefit associated with sevelamer in the INDEPENDENT study. Clin Nephrol 2016, 86(9):113\u2013124.","journal-title":"Clinical Nephrology"},{"issue":"4 Suppl 3","key":"1056_CR13","first-page":"S1","volume":"42","author":"F National Kidney","year":"2003","unstructured":"National Kidney F. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1\u2013201.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1056_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","volume":"55","author":"K Uhlig","year":"2010","unstructured":"Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, Sprague SM, Goldfarb S. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2010;55(5):773\u201399.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1056_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","volume":"70","author":"T Isakova","year":"2017","unstructured":"Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutierrez OM, Bansal V, Rosas SE, Nigwekar S, Yee J, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737\u201351.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1056_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ, Komaba H, Ando R, Kakuta T, Fujii H, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17(3):247\u201388.","journal-title":"Ther Apher Dial"},{"issue":"12","key":"1056_CR17","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1097\/01.ASN.0000100127.54107.57","volume":"14","author":"DA Goodkin","year":"2003","unstructured":"Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol. 2003;14(12):3270\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"10041","key":"1056_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(16)30448-2","volume":"388","author":"BM Robinson","year":"2016","unstructured":"Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388(10041):294\u2013306.","journal-title":"Lancet"},{"issue":"3","key":"1056_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1042\/BJ20131282","volume":"456","author":"S Yamamoto","year":"2013","unstructured":"Yamamoto S, Kazama JJ, Fukagawa M. Autophagy: a two-edged sword in diabetes mellitus. Biochem J. 2013;456(3):e1\u20133.","journal-title":"Biochem J"},{"issue":"8","key":"1056_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/aje\/kwf110","volume":"156","author":"JM Taylor","year":"2002","unstructured":"Taylor JM, Cooper KL, Wei JT, Sarma AV, Raghunathan TE, Heeringa SG. Use of multiple imputation to correct for nonresponse bias in a survey of urologic symptoms among African-American men. Am J Epidemiol. 2002;156(8):774\u201382.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1056_CR21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","volume":"12","author":"Guideline Working Group JSfDT","year":"2008","unstructured":"Guideline Working Group JSfDT. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial. 2008;12(6):514\u201325.","journal-title":"Ther Apher Dial"},{"issue":"5","key":"1056_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000327654","volume":"33","author":"M Fukagawa","year":"2011","unstructured":"Fukagawa M, Komaba H, Onishi Y, Fukuhara S, Akizawa T, Kurokawa K, Group M-DS. Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D. Am J Nephrol. 2011;33(5):427\u201337.","journal-title":"Am J Nephrol"},{"issue":"1","key":"1056_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40620-015-0202-4","volume":"29","author":"Maurizio Gallieni","year":"2015","unstructured":"Gallieni M, De Luca N, Santoro D, Meneghel G, Formica M, Grandaliano G, Pizzarelli F, Cossu M, Segoloni G, Quintaliani G et al: Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study. J Nephrol 2016, 29(1):71\u201378.","journal-title":"Journal of Nephrology"},{"issue":"1","key":"1056_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","volume":"132","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drueke TB, Herzog CA, London GM, Mahaffey KW, et al. Cinacalcet, fibroblast growth Factor-23, and cardiovascular disease in hemodialysis: the evaluation of Cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation. 2015;132(1):27\u201339.","journal-title":"Circulation"},{"issue":"6","key":"1056_CR25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359(6):584\u201392.","journal-title":"N Engl J Med"},{"issue":"3","key":"1056_CR26","doi-asserted-by":"publisher","first-page":"e0173831","DOI":"10.1371\/journal.pone.0173831","volume":"12","author":"Ricardo Villa-Bellosta","year":"2017","unstructured":"Villa-Bellosta R, Rodriguez-Osorio L, Mas S, Abadi Y, Rubert M, de la Piedra C, Gracia-Iguacel C, Mahillo I, Ortiz A, Egido J et al: A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients. PLoS One 2017, 12(3):e0173831.","journal-title":"PLOS ONE"},{"issue":"10","key":"1056_CR27","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/ndt\/gfp260","volume":"24","author":"C Drechsler","year":"2009","unstructured":"Drechsler C, Krane V, Grootendorst DC, Ritz E, Winkler K, Marz W, Dekker F, Wanner C, German D, Dialysis Study I. The association between parathyroid hormone and mortality in dialysis patients is modified by wasting. Nephrol Dial Transplant. 2009;24(10):3151\u20137.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1056-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T19:05:45Z","timestamp":1570215945000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1056-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1056-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IRB approval was obtained from E&I West Coast Board on May 23, 2016, IRB # IRB00007807. Written, informed consent was obtained from participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.Y. has received honoraria from Kyowa Hakko Kirin. H.K. has received honoraria, consulting fees, and\/or grant\/research support from Bayer Yakuhin and Kyowa Hakko Kirin. M.T. has received consulting fees from Kyowa Hakko Kirin. T.N. is an employee of Kyowa Hakko Kirin. M.F. has received honoraria, consulting fees, and\/or grant\/research support from Astellas Pharma, Bayer Yakuhin, Kyowa Hakko Kirin, Ono Pharmaceutical, and Torii Pharmaceutical. A.K., B.A.B., R.L.P., and B.M.R. are employees for the non-profit research organization Arbor Research Collaborative for Health, which has designed and carries out the Dialysis Outcomes and Practice Patterns Study (DOPPS) Program. Grants are made to Arbor Research Collaborative for Health and not to individual investigators. The remaining authors have no conflicts to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"253"}}